Viridian Therapeutics, Inc.\DE (VRDN) Insider Ownership

Historic Insider Ownership Trends

VRDN's three largest insider shareholders as of March 23, 2026 are Funds Management Llc Fairmount (Director, 3.91Mn shares), Life Sciences Public Fund, L.P. Frazier (TenPercentOwner, 1.51Mn shares), Jonathan Violin (Chief Executive Officer, 480.90K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Funds Management Llc Fairmount 0 3,914,458 27 Oct, 2025
Life Sciences Public Fund, L.P. Frazier 1,505,200 0 28 Sep, 2021
Jonathan Violin Chief Executive Officer 480,905 0 07 Feb, 2023
Stephen F. Mahoney President And Ceo 33,349 0 09 Mar, 2026
Lara Meisner Chief Legal Officer 29,971 0 20 Jun, 2023
Thomas W. Beetham Chief Operating Officer 13,361 0 09 Mar, 2026
Seth Harmon Chief Financial Officer 7,850 0 09 Mar, 2026
Jennifer Tousignant Chief Legal Officer 3,494 0 09 Mar, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
03 Mar, 2026 Thomas W. Beetham Common Stock D 3,048 $30.19 13,361 D F
03 Mar, 2026 Jennifer Tousignant Common Stock D 1,675 $30.19 3,494 D F
03 Mar, 2026 Stephen F. Mahoney Common Stock D 7,408 $30.19 33,349 D F
03 Mar, 2026 Seth Harmon Common Stock D 2,031 $30.19 7,850 D F
02 Mar, 2026 Radhika Tripuraneni Stock Option (Right to Buy) A 95,800 $0.00 95,800 D A
03 Mar, 2026 Thomas W. Beetham Common Stock A 9,409 - 16,409 D M
03 Mar, 2026 Stephen F. Mahoney Common Stock A 18,357 - 40,757 D M
03 Mar, 2026 Seth Harmon Common Stock A 6,267 - 9,881 D M
03 Mar, 2026 Jennifer Tousignant Common Stock A 5,169 - 5,169 D M
02 Mar, 2026 Radhika Tripuraneni Restricted Stock Units A 19,150 $0.00 19,150 D A
03 Mar, 2026 Stephen F. Mahoney Common Stock D 7,627 $29.32 33,130 D F
03 Mar, 2026 Seth Harmon Common Stock D 2,091 $29.32 7,790 D F
03 Mar, 2026 Jennifer Tousignant Common Stock D 1,724 $29.32 3,445 D F
03 Mar, 2026 Thomas W. Beetham Common Stock D 3,138 $29.32 13,271 D F
02 Mar, 2026 Stephen F. Mahoney Stock Option (Right to Buy) A 559,600 $0.00 559,600 D A
02 Mar, 2026 Thomas W. Beetham Stock Option (Right to Buy) A 176,550 $0.00 176,550 D A
02 Mar, 2026 Seth Harmon Stock Option (Right to Buy) A 102,850 $0.00 102,850 D A
02 Mar, 2026 Jennifer Tousignant Stock Option (Right to Buy) A 119,300 $0.00 119,300 D A
02 Mar, 2026 Jennifer Tousignant Restricted Stock Units A 23,850 $0.00 23,850 D A
02 Mar, 2026 Thomas W. Beetham Restricted Stock Units A 35,300 $0.00 35,300 D A